Sphingolipids in parasitic protozoa

Advances in Experimental Medicine and Biology

Volumn 688, Issue , 2010, Pages 238-248

  Zhang, Kai ^b   Bangs, James D ^b   Beverley, Stephen M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN;

AMASTIGOTE; ARTICLE; FUNGAL VIRULENCE; GIARDIA LAMBLIA; HUMAN; KINETOPLASTIDA; LEISHMANIA; LEISHMANIASIS; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL GENETICS; PROTOZOON; TOXOPLASMA GONDII; TRICHOMONAS VAGINALIS; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; ANIMAL; GENETICS; METABOLISM; PARASITE; PATHOGENICITY; REVIEW; TOXOPLASMA; TRYPANOSOMA;

PROTOZOA;

ANIMALS; GIARDIA LAMBLIA; HUMANS; LEISHMANIA; PARASITES; PLASMODIUM FALCIPARUM; SPHINGOLIPIDS; TOXOPLASMA; TRICHOMONAS VAGINALIS; TRYPANOSOMA;

EID: 78049521354     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6741-1_17     Document Type: Article

References (80)

1. Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol 2006; 22:583-588. (Pubitemid 44781088)
2. Simarro PP, Jannin J, Cattand P. Eliminating human African trypanosomiasis: Where do we stand and what comes next? PLoS Med 2008; 5:e55.
3. Cunningham AC. Parasitic adaptive mechanisms in infection by Leishmania. Exp Mol Pathol 2002; 72:132-141.
4. Croft SL, Coombs GH. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 2003; 19:502-508. (Pubitemid 37329659)
5. Sonda S, Sala G, Ghidoni R et al. Inhibitory effect of aureobasidin A on Toxoplasma gondii. Antimicrob Agents Chemother 2005; 49:1794-1801. (Pubitemid 40631591)
6. Zhang K, Showalter M, Revollo J et al. Sphingolipids are essential for differentiation but not growth in Leishmania. EMBO J 2003; 22:6016-6026. (Pubitemid 37463245)
7. Hsu FF, Turk J, Zhang K et al. Characterization of inositol phosphorylceramides from Leishmania major by tandem mass spectrometry with electrospray ionization. J Am Soc Mass Spectrom 2007; 18:1591-1604. (Pubitemid 47302318)
8. Guther ML, Lee S, Tetley L et al. GPI-anchored proteins and free GPI glycolipids of procyclic form Trypanosoma brucei are nonessential for growth, are required for colonization of the tsetse fly and are not the only components of the surface coat. Mol Biol Cell 2006; 17:5265-5274. (Pubitemid 44907367)
9. Fridberg A, Olson CL, Nakayasu ES et al. Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei. J Cell Sci 2008; 121:522-535. (Pubitemid 351405061)
10. Sutterwala SS, Hsu FF, Sevova ES et al. Developmentally regulated sphingolipid synthesis in African trypanosomes. Mol Microbiol 2008; 70:281-296.
11. Patnaik PK, Field MC, Menon AK et al. Molecular species analysis of phospholipids from Trypanosoma brucei bloodstream and procyclic forms. Mol Biochem Parasitol 1993; 58:97-105. (Pubitemid 223039627)
12. Uemura A, Watarai S, Kushi Y et al. Analysis of neutral glycosphingolipids from Trypanosoma brucei. Vet Parasitol 2006; 140:264-272. (Pubitemid 44767522)
13. Bertello LE, Goncalvez MF, Colli W et al. Structural analysis of inositol phospholipids from Trypanosoma cruzi epimastigote forms. Biochem J 1995; 310(Pt 1):255-261.
14. Uhrig ML, Couto AS, Colli W et al. Characterization of inositolphospholipids in Trypanosoma cruzi trypomastigote forms. Biochim Biophys Acta 1996; 1300:233-239. (Pubitemid 26194124)
15. Quinones W, Urbina JA, Dubourdieu M et al. The glycosome membrane of Trypanosoma cruzi epimastigotes: Protein and lipid composition. Exp Parasitol 2004; 106:135-149. (Pubitemid 38686283)
16. Gerold P, Schwarz RT. Biosynthesis of glycosphingolipids de-novo by the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 2001; 112:29-37. (Pubitemid 32144834)
17. Landoni M, Duschak VG, Peres VJ et al. Plasmodium falciparum biosynthesizes sulfoglycosphingolipids. Mol Biochem Parasitol 2007; 154:22-29. (Pubitemid 46887619)
18. Azzouz N, Rauscher B, Gerold P et al. Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii. Int J Parasitol 2002; 32:677-684. (Pubitemid 34327586)
19. Costello CE, Glushka J, van Halbeek H et al. Structural characterization of novel inositol phosphosphingolipids of Tritrichomonas foetus and Trichomonas vaginalis. Glycobiology 1993; 3:261-269. (Pubitemid 23232160)
20. Singh BN, Costello CE, Beach DH. Structures of glycophosphosphingolipids of Tritrichomonas foetus: A novel glycophosphosphingolipid. Arch Biochem Biophys 1991; 286:409-418.
21. Beach DH, Holz GG Jr, Singh BN et al. Phospholipid metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol Biochem Parasitol 1991; 44:97-108.
22. Kaneda Y, Goutsu T. Lipid analysis of Giardia lamblia and its culture medium. Ann Trop Med Parasitol 1988; 82:83-90.
23. Hernandez Y, Shpak M, Duarte TT et al. Novel role of sphingolipid synthesis genes in regulating giardial encystation. Infect Immun 2008; 76:2939-2949.
24. Fernandes AP, Nelson K, Beverley SM. Evolution of nuclear ribosomal RNAs in kinetoplastid protozoa: Perspectives on the age and origins of parasitism. Proc Natl Acad Sci USA 1993; 90:11608-11612. (Pubitemid 24008688)
25. Wassef MK, Fioretti TB, Dwyer DM. Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. Lipids 1985; 20:108-115.
26. Kaneshiro ES, Jayasimhulu K, Lester RL. Characterization of inositol lipids from Leishmania donovani promastigotes: Identification of an inositol sphingophospholipid. J Lipid Res 1986; 27:1294-1303. (Pubitemid 17009491)
27. Denny PW, Goulding D, Ferguson MA et al. Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity. Mol Microbiol 2004; 52:313-327. (Pubitemid 38520705)
28. McConville MJ, Blackwell JM. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J Biol Chem 1991; 266:15170-15179. (Pubitemid 21907632)
29. Winter G, Fuchs M, McConville MJ et al. Surface antigens of Leishmania mexicana amastigotes: Characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid. J Cell Sci 1994; 107 (Pt 9):2471-2482. (Pubitemid 24292495)
30. Schneider P, Rosat JP, Ransijn A et al. Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major. Biochem J 1993; 295:555-564. (Pubitemid 23315198)
31. Ivens AC, Peacock CS, Worthey EA et al. The genome of the kinetoplastid parasite, Leishmania major. Science 2005; 309:436-442. (Pubitemid 40994677)
32. Denny PW, Shams-Eldin H, Price HP et al. The protozoan inositol phosphorylceramide synthase: A novel drug target that defines a new class of sphingolipid synthase. J Biol Chem 2006; 281:28200-28209. (Pubitemid 44414534)
33. Zhang K, Pompey JM, Hsu FF et al. Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania. EMBO J 2007; 26:1094-1104.
34. Zhang K, Hsu FF, Scott DA et al. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis. Mol Microbiol 2005; 55:1566-1578. (Pubitemid 40342080)
35. Ghosh S, Bhattacharyya S, Das S et al. Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival. Mol Cell Biochem 2001; 223:47-60. (Pubitemid 32952090)
36. Ghosh S, Bhattacharyya S, Sirkar M et al. Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: Involvement of extracellular signal-regulated kinase. Infect Immun 2002; 70:6828-6838. (Pubitemid 35387915)
37. Spath GF, Lye LF, Segawa H et al. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 2003; 301:1241-1243. (Pubitemid 37052214)
38. Ilg T, Demar M, Harbecke D. Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice. J Biol Chem 2001; 276:4988-4997.
39. Nagiec MM, Nagiec EE, Baltisberger JA et al. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J Biol Chem 1997; 272:9809-9817. (Pubitemid 27171646)
40. Takesako K, Ikai K, Haruna F et al. Aureobasidins, new antifungal antibiotics: Taxonomy, fermentation, isolation and properties. J Antibiot 1991; 44:919-924.
41. Tanaka AK, Valero VB, Takahashi HK et al. Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A. J Antimicrob Chemother 2007; 59:487-492. (Pubitemid 47073455)
42. Godfrey DG. Phospholipids of Trypanosoma lewisi, T. vivax, T. congolense and T. brucei. Exp Parasitol 1967; 20:106-118.
43. Fridberg A, Olsen CL, Nakayasu ES et al. Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei. J Cell Sci 2008; 121:522-535. (Pubitemid 351405061)
44. Sutterwala SS, Creswell CH, Sanyal S et al. De novo sphingolipid synthesis is essential for viability, but not transport of glycosylphosphatidylinositol-anchored proteins in African trypanosomes. Eukaryotic Cell 2007; 6:454-464. (Pubitemid 46492333)
45. Da Silveira JF, Colli W. Chemical composition of the plasma membrane from epimastigote forms of Trypanosoma cruzi. Biochimica et Biophysica Acta 1981; 644:341-350.
46. Oliveira MM, Timm SL, Costa SCG. Lipid composition of Trypanosoma cruzi. Comp Biochem Physiol 1977; 58B:195-199. (Pubitemid 8201941)
47. Quiñones W, Urbina JA, Dubourdieu M et al. The glycosome membrane of Trypansoma cruzi epimastigotes: Protein and lipid composition. Exp Parasitol 2004; 106:135-149. (Pubitemid 38686283)
48. Bertello L, Goncalvez MF, Colli W et al. Structural analysis of inositol phospholipids from Trypanosoma cruzi epimastigote forms. Biochem J 1995; 310:255-261.
49. Bertello LE, Andrews NW, Lederkremer RM. Developmentally regulated expression of ceramide in Trypanosoma cruzi. Mol Biochem Parasitol 1996:143-151. (Pubitemid 26241886)
50. Salto ML, Bertello LE, Vieira M et al. Formation and remodeling of inositolphosphoceramide during differentiation of Trypanosoma cruzi from trypomastigote to amastigote. Eukaryot Cell 2003; 2:756-768. (Pubitemid 36996721)
51. Barreto-Bergter E, Vermelho AB, Hartmann R et al. Structural characterization of neutral glycosphingolipids from Trypanosoma cruzi. Mol Biochem Parasitol 1992; 51:263-270.
52. Vermelho AB, Meirelles MNL, Pereira MC et al. Heart muscle cells share common neutral glycosphingolipids with Trypanosoma cruzi. Acta Tropica 1997; 64:131-143. (Pubitemid 27191477)
53. Figueiredo JM, Dias WB, Mendonca-Previato L et al. Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi. Biochem J 2005; 387:519-529. (Pubitemid 40571239)
54. Lederkremer RM, Casal OL, Tanaka CT et al. Ceramide and inositol content of the lipopeptidophosphoglycan from Trypanosoma cruzi. Biochem Biophys Res Commun 1978; 85:1268-1274. (Pubitemid 9088326)
55. Lederkremer RM, Lima C, Ramirez MI et al. Structural features of the lipopeptidophosphoglycan from Trypanosoma cruzi common with the glycophosphatidylinositol anchors. Eur J Biochem 1990; 192:337-345. (Pubitemid 20283500)
56. Lederkremer RM, Lima C, Ramirez MI et al. Complete structure of the glycan of lipopeptidophosphoglycan from Trypanosoma cruzi epimastigotes. J Biol Chem 1991; 266:23670-23675.
57. Previato JO, Gorin PAJ, Mazurek M et al. Primary structure of the oligosaccharide chain of lipopeptidophosphoglycan of epimastigote forms of Trypanosoma cruzi. J Biol Chem 1990; 265:2518-2526.
58. Acosta-Serrano A, Schenkman SNY, Mehlert A et al. The lipid structure of the glycosylphosphatidylinositol- anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. J Biol Chem 1995; 270:27244-27253.
59. Lederkremer RM, Lima CE, Ramirez MI et al. Hexadecylpalmitoylglycerol or ceramide is linked to similar glycophosphoinositol anchor-like structures in Trypanosoma cruzi. Eur J Biochem 1993; 218:929-936. (Pubitemid 24010059)
60. Previato JO, Jones C, Xavier MT et al. Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein form epimastigote forms of Trypanosoma cruzi Y-strain. J Biol Chem 1995; 270:7241-7250.
61. Heise N, Cardoso de Almeida ML, Ferguson MAJ. Characterization of the lipid moiety of the glycosylphosphatidyl inositol anchor of Trypanosoma cruzi 1G7-antigen. Mol Biochem Parasitol 1995; 70:71-84.
62. Pittet M, Conzelman A. Biosynthesis and function of GPI proteins in the yeast Saccharomyces cerevisiae. Biochimica et Biophysica Acta 2007; 1771:405-420. (Pubitemid 46428606)
63. Bertello LE, Alves MJ, Colli W et al. Inositolphosphoceramide is not a substrate for the first steps in the biosynthesis of glycoinositolphospholipids in Trypanosoma cruzi. Mol Biochem Parasitol 2004; 133:71-80. (Pubitemid 37510310)
64. Tafesse FG, Ternes P, Holthuis JC. The multigenic sphingomyelin synthase family. J Biol Chem 2006; 281:29421-29425. (Pubitemid 44536948)
65. Huitema K, van den Dikkenberg J, Brouwers JF et al. Identification of a family of animal sphingomyelin synthases. Eur Mol Biol Organ J 2004; 23:33-44. (Pubitemid 38165745)
66. Haldar K, Uyetake L, Ghori N et al. The accumulation and metabolism of a fluorescent ceramide derivative in Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol 1991; 49:143-156.
67. Couto AS, Caffaro C, Uhrig ML et al. Glycosphingolipids in Plasmodium falciparum. Presence of an active glucosylceramide synthase. Eur J Biochem 2004; 271:2204-2214. (Pubitemid 38747989)
68. Lauer SA, Ghori N, Haldar K. Sphingolipid synthesis as a target for chemotherapy against malaria parasites. Proc Natl Acad Sci USA 1995; 92:9181-9185.
69. Lauer SA, Rathod PK, Ghori N et al. A membrane network for nutrient import in red cells infected with the malaria parasite. Science 1997; 276:1122-1125. (Pubitemid 27218122)
70. Lauer S, VanWye J, Harrison T et al. Vacuolar uptake of host components and a role for cholesterol and sphingomyelin in malarial infection. EMBO J 2000; 19:3556-3564. (Pubitemid 30462114)
71. Hanada K, Palacpac NM, Magistrado PA et al. Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy. J Exp Med 2002; 195:23-34. (Pubitemid 34074493)
72. Pankova-Kholmyansky I, Flescher E. Potential new antimalarial chemotherapeutics based on sphingolipid metabolism. Chemotherapy 2006; 52:205-209. (Pubitemid 43882420)
73. Labaied M, Dagan A, Dellinger M et al. Anti-Plasmodium activity of ceramide analogs. Malar J 2004; 3:49.
74. Singh BN, Beach DH, Lindmark DG et al. Identification of the lipid moiety and further characterization of the novel lipophosphoglycan-like glycoconjugates of Trichomonas vaginalis and Trichomonas foetus. Arch Biochem Biophys 1994; 309:273-280. (Pubitemid 24172652)
75. Bastida-Corcuera FD, Okumura CY, Colocoussi A et al. Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells. Eukaryot Cell 2005; 4:1951-1958. (Pubitemid 41636887)
76. Fichorova RN, Trifonova RT, Gilbert RO et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 2006; 74:5773-5779. (Pubitemid 44484563)
77. Gibson GR, Ramirez D, Maier J et al. Giardia lamblia: Incorporation of free and conjugated fatty acids into glycerol-based phospholipids. Exp Parasitol 1999; 92:1-11. (Pubitemid 29370075)
78. Das S, Castillo C, Stevens T. Phospholipid remodeling/generation in Giardia: The role of the Lands cycle. Trends Parasitol 2001; 17:316-319. (Pubitemid 32553746)
79. Mohareb EW, Rogers EJ, Weiner EJ et al. Giardia lamblia: Phospholipid analysis of human isolates. Ann Trop Med Parasitol 1991; 85:591-597.
80. Sonda S, Stefanic S, Hehl AB. A sphingolipid inhibitor induces a cytokinesis arrest and blocks stage differentiation in Giardia lamblia. Antimicrob Agents Chemother 2008; 52:563-569. (Pubitemid 351170829)